In the competitive world revolving around HTA, insurance, reimbursement, patient access service etc. it becomes obligatory for the pharma companies to place their products successfully in the formulary and make sure they receive suitable reimbursement.
We at MarksMan can help you by creating predictors and conducting analogue studies to facilitate pharma manufacturers achieve reimbursement for their product.
Our reimbursement services include:
- Developing applications based on cost-minimization analysis, cost benefit analysis, cost utilization analysis and budget impact
- Adaptation of health-economic models
- Conduct reimbursement assessments
- Support pharmaceutical companies understand healthcare reimbursement environment in each country